{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:28:48Z","timestamp":1791404928489,"version":"4.3.3"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002838","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T20:26:15Z","timestamp":1401395175000},"page":"e2838","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Exploring the Potential of Flubendazole in Filariasis Control: Evaluation of the Systemic Exposure for Different Pharmaceutical Preparations"],"prefix":"10.1371","volume":"8","author":[{"given":"Laura","family":"Ceballos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lanusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"ref1","unstructured":"WHO. (2010) First WHO report on neglected tropical diseases 2010: working to overcome the global impact of neglected tropical diseases. Geneva: World Health Organization"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"MJ Taylor","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2012.12.004","article-title":"Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in vitro","volume":"36","author":"M Longo","year":"2013","journal-title":"Reprod Toxicol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.eye.6701962","article-title":"Ivermectin and onchocerciasis: is it all solved?","volume":"19","author":"AD Hopkins","year":"2005","journal-title":"Eye (Lond.)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans","volume":"40","author":"TG Geary","year":"2010","journal-title":"Int J Parasitol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/eri.11.30","article-title":"Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs","volume":"5","author":"CD Mackenzie","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/QCO.0b013e328359f04a","article-title":"Are new anthelmintics needed to eliminate human helminthiases?","volume":"25","author":"TG Geary","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0001-706X(93)90010-9","article-title":"Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in <italic>Mastomys coucha<\/italic> infected with <italic>Litomosoides carinii<\/italic>, <italic>Acanthocheilonema viteae<\/italic>, <italic>Brugia malayi<\/italic> and <italic>B. pahangi<\/italic>","volume":"52","author":"H Zahner","year":"1993","journal-title":"Acta Trop"},{"key":"ref9","unstructured":"EMEA (1997) EMEA\/MRL\/267\/97-FINAL. The European Agency for the Evaluation of Medicinal Products. Flubendazol, Summary Report 2. Veterinary Medicines Evaluation Unit, Committee for Veterinary Medicinal Products, London, UK. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Maximum_Residue_Limits_-_Report\/2009\/11\/WC500014288.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Maximum_Residue_Limits_-_Report\/2009\/11\/WC500014288.pdf<\/ext-link>"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2885.2004.00616.x","article-title":"Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite difussion ability","volume":"27","author":"L Moreno","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0022149X00005939","article-title":"A review of methods for testing compounds for filaricidal activity","volume":"53","author":"DA Denham","year":"1979","journal-title":"J Helminthol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(83)92753-8","article-title":"Comparison of flubendazole and diethylcarbamazine in the treatment of onchocerciasis","volume":"321","author":"A Dominguez-Vazquez","year":"1983","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198815020-00001","article-title":"Clinical pharmacokinetics of anthelmintic drugs","volume":"15","author":"G Edwards","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Fr\u00f6mming K, Szejtli J (1994) Cyclodextrins in pharmacy. Kluwer Academic Publishers, Dordrecht, The Netherlands.","DOI":"10.1007\/978-94-015-8277-3"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Historical Perspectives. Cyclodextrins and their pharmaceutical applications","volume":"329","author":"T Loftsson","year":"2007","journal-title":"Int J Pharm"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1746-6148-8-71","article-title":"Evaluation of flubendazole formulations for use in sheep. Pharmacokinetic assessment of a cyclodextrin-based solution","volume":"1","author":"L Ceballos","year":"2012","journal-title":"BMC Vet Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.parint.2009.07.006","article-title":"Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice","volume":"58","author":"L Ceballos","year":"2009","journal-title":"Parasitol Int"},{"key":"ref18","first-page":"351","article-title":"Int J Pharm","volume":"250","author":"J Garc\u00eda","year":"2003","journal-title":"Int J Pharm"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/AAC.48.3.1051-1054.2004","article-title":"Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers","volume":"48","author":"IM Rigter","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","unstructured":"Guide for the Care and Use of Laboratory Animals. Editors. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Source 8th edition. Washington (DC): National Academies Press (US); 2011. The National Academies Collection: Reports funded by National Institutes of Health."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics. 2nd edn., Revised and Expanded. pp. 45\u2013109. Marcel Dekker, New York, NY, USA.","DOI":"10.1201\/b14095"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03602539308993977","article-title":"Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants","volume":"25","author":"CE Lanusse","year":"1993","journal-title":"Drug Metab Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0169-4758(93)90162-9","article-title":"Mechanistic approaches to quantitate anthelmintic absorption by gastrointestinal nematodes","volume":"9","author":"D Thompson","year":"1993","journal-title":"Parasitol Today"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2885.2008.00953.x","article-title":"Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs","volume":"31","author":"L Alvarez","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2010.07.002","article-title":"Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-cyclodextrin following subcutaneous injection in sheep","volume":"397","author":"Z Wu","year":"2010","journal-title":"Int J Pharm"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.1990.51.09.1459","article-title":"Comparison of pharmacokinetic variables for two injectable formulations of netobimin administered to calves","volume":"51","author":"CE Lanusse","year":"1990","journal-title":"Am J Vet Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2885.1990.tb00773.x","article-title":"The benzimidazole anthelmintcs agents-a review","volume":"13","author":"Q MacKellar","year":"1990","journal-title":"J Vet Pharm Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/0020-7519(95)00055-0","article-title":"Development of an injectable formulation of ABZ and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode","volume":"25","author":"J Rodrigues","year":"1995","journal-title":"Int J Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2003.11.030","article-title":"The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs","volume":"272","author":"K Daniel-Mwambete","year":"2004","journal-title":"Int J Pharm"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1128\/AAC.05105-11","article-title":"Comparative performance of flubendazole and albendazole in cystic echinococcosis: <italic>ex vivo<\/italic> activity, plasma\/cysts disposition and efficacy in infected mice","volume":"55","author":"L Ceballos","year":"2011","journal-title":"Antimicrob Agents chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-3659(98)00182-5","article-title":"Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing","volume":"59","author":"M Masson","year":"1999","journal-title":"J Control Release"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2460\/ajvr.1986.47.02.447","article-title":"In vitro sulfoxidation of albendazole by ovine liver microsomes: assay and frequency of various xenobiotics","volume":"47","author":"P Galtier","year":"1986","journal-title":"Am J Vet Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/dmd.32.5.536","article-title":"Comparative hepatic and extrahepatic enantioselective sulphoxidation of albendazole and fenbendazole in sheep and cattle","volume":"32","author":"G Virkel","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bcp.2008.07.002","article-title":"Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep","volume":"76","author":"L Mat\u00e9","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"ref35","unstructured":"Ceballos L, Alvarez L, Moreno L, MacKenzie C, Geary T, <etal>et al<\/etal>.. (2012b) Development of Flubendazole as a Macrofilaricide Compound -Systemic Exposure in Pigs Treated with Different Formulations-. 12<sup>th<\/sup> International Congress of the European Association for Veterinary Pharmacology and Toxicology, Amsterdam, Holland."},{"key":"ref36","first-page":"211","article-title":"Comparative assessment of albendazole and triclabendazole ovicidal activity on <italic>Fasciola hepatica<\/italic> eggs. Vet","volume":"164","author":"L Alvarez","year":"2009","journal-title":"Parasitol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000342924","article-title":"Nematodicidal activity of flubendazole and its reduced metabolite on a murine model of Trichinella spiralis infection","volume":"58","author":"L Urbizu","year":"2012","journal-title":"Chemotherapy"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:59:30Z","timestamp":1746248370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002838"}},"subtitle":[],"editor":[{"given":"Patrick J.","family":"Lammie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002838","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}